Weight Management
Semaglutide and Tirzepatide: Understanding the Difference
Two weight-management options that are frequently compared, described without outcome claims or league tables.
January 20, 2026 · 7 min read
Demonstration notice. ClientRx is a fictional demonstration telehealth brand. Products, pricing, providers, pharmacies, and testimonials shown are illustrative only.
Different mechanisms, not a ranking
Semaglutide acts on the GLP-1 pathway. Tirzepatide acts on both the GIP and GLP-1 pathways. That is a genuine pharmacological difference, and it is often reported online as though it settles which product is better. It does not.
Which product suits a person depends on their history, tolerance, other medications, and clinical judgment. Some people tolerate one and not the other. Some should take neither.
Branded versus compounded
Both active ingredients appear in FDA-approved branded products with specific approved indications. Compounded formulations containing the same active ingredient are different products: they are not FDA-approved and are not reviewed by the FDA for safety or effectiveness.
It matters that marketing does not blur those two categories. A compounded tirzepatide preparation is not Zepbound or Mounjaro, and describing it that way would be inaccurate.
What we will not tell you
We will not publish an expected percentage of body weight lost, and we will not compare the two products with a number. Those figures come from trials with specific populations, protocols, and support structures, and repeating them as a marketing promise misrepresents them.
Next steps
Read the safety information for any program you are considering, then check what the monthly price includes before you select anything.